Simplex Trading’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $139K | Sell |
31,096
-67,142
| -68% | -$336K | ﹤0.01% | 4715 |
|
|
2025
Q4 | $518K | Buy |
98,238
+65,466
| +200% | +$330K | ﹤0.01% | 3275 |
|
|
2025
Q3 | $173K | Buy |
32,772
+25,321
| +340% | +$161K | ﹤0.01% | 5114 |
|
|
2025
Q2 | $42K | Buy |
+7,451
| New | +$42.4K | ﹤0.01% | 6088 |
|
|
2024
Q2 | – | Sell |
-2,154
| Closed | -$11K | – | 8634 |
|
|
2024
Q1 | $15K | Sell |
2,154
-2,614
| -55% | -$16.6K | ﹤0.01% | 7302 |
|
|
2023
Q4 | $23K | Sell |
4,768
-9,360
| -66% | -$41.2K | ﹤0.01% | 6790 |
|
|
2023
Q3 | $59K | Buy |
14,128
+13,418
| +1,890% | +$50.8K | ﹤0.01% | 5643 |
|
|
2023
Q2 | $2K | Buy |
+710
| New | +$2.48K | ﹤0.01% | 8348 |
|
|
2022
Q2 | – | Sell |
-78
| Closed | – | – | 9806 |
|
|
2022
Q1 | $0 | Buy |
78
+71
| +1,014% | +$488 | ﹤0.01% | 10255 |
|
|
2021
Q4 | $0 | Sell |
7
-1,309
| -99% | -$24K | ﹤0.01% | 10348 |
|
|
2021
Q3 | $50K | Sell |
1,316
-104
| -7% | -$3.33K | ﹤0.01% | 7500 |
|
|
2021
Q2 | $55K | Sell |
1,420
-268
| -16% | -$10.9K | ﹤0.01% | 7526 |
|
|
2021
Q1 | $0 | Buy |
+1,688
| New | +$93K | ﹤0.01% | 8628 |
|
|
2020
Q4 | – | Sell |
-349
| Closed | -$11.9K | – | 8227 |
|
|
2020
Q3 | $8K | Sell |
349
-203
| -37% | -$12.8K | ﹤0.01% | 6877 |
|
|
2020
Q2 | $40K | Buy |
552
+134
| +32% | +$9.26K | ﹤0.01% | 5672 |
|
|
2020
Q1 | $21K | Sell |
418
-1,316
| -76% | -$87.9K | ﹤0.01% | 5901 |
|
|
2019
Q4 | $141K | Buy |
1,734
+1,157
| +201% | +$81.6K | ﹤0.01% | 4121 |
|
|
2019
Q3 | $32K | Buy |
577
+460
| +393% | +$34.4K | ﹤0.01% | 5425 |
|
|
2019
Q2 | $13K | Buy |
+117
| New | +$19.6K | ﹤0.01% | 5930 |
|
|
2018
Q3 | – | Sell |
-128
| Closed | -$45.4K | – | 7301 |
|
|
2018
Q2 | $51K | Sell |
128
-86
| -40% | -$37.6K | ﹤0.01% | 5026 |
|
|
2018
Q1 | $76K | Buy |
214
+165
| +337% | +$61.3K | ﹤0.01% | 2022 |
|
|
2017
Q4 | $19K | Sell |
49
-636
| -93% | -$263K | ﹤0.01% | 3336 |
|
|
2017
Q3 | $292K | Buy |
685
+488
| +248% | +$131K | 0.01% | 971 |
|
|
2017
Q2 | $31K | Buy |
197
+193
| +4,825% | +$26.3K | ﹤0.01% | 2829 |
|
|
2017
Q1 | $0 | Buy |
+4
| New | +$516 | ﹤0.01% | 6050 |
|
|
2016
Q2 | – | Sell |
-8
| Closed | -$547 | – | 5713 |
|
|
2016
Q1 | $0 | Buy |
+8
| New | +$530 | ﹤0.01% | 5474 |
|
|
2015
Q3 | – | Sell |
-201
| Closed | -$26.7K | – | 5415 |
|
|
2015
Q2 | $25K | Buy |
+201
| New | +$30.2K | ﹤0.01% | 2255 |
|
Other funds holding ABEO
NCM
ACM
CCC
SCM
VCM
PBM
KCM
Simplex Trading's ABEO Position: Q1 2026 in Review
Simplex Trading reduced its Abeona Therapeutics (ABEO) stake by 68% in Q1 2026, selling an estimated $336K and leaving 31,096 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #4715.
Simplex Trading first reported a position in ABEO in Q2 2015 and has held it in 27 quarters since. The position peaked at $518K in Q4 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.
- Simplex Trading held 31,096 shares of Abeona Therapeutics worth $139K as of Q1 2026.
- Simplex Trading sold 67,142 Abeona Therapeutics shares in Q1 2026, an estimated $336K.
- Abeona Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4715 holding.
- Simplex Trading first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 27 quarters since.
- Simplex Trading's Abeona Therapeutics position peaked at $518K in Q4 2025.
- 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.